scholarly article | Q13442814 |
P356 | DOI | 10.1016/0140-6736(93)90910-9 |
P698 | PubMed publication ID | 8099155 |
P50 | author | Claire L Shovlin | Q63150502 |
P2093 | author name string | I Roberts | |
H A Simmonds | |||
J M Hughes | |||
A D Webster | |||
L Fairbanks | |||
S Deacock | |||
R Lechler | |||
P433 | issue | 8858 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adenosine deaminase deficiency | Q1055374 |
P304 | page(s) | 1471 | |
P577 | publication date | 1993-06-01 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Adult presentation of adenosine deaminase deficiency | |
P478 | volume | 341 |
Q72025682 | Adenosine Deaminase (ADA) Deficiency as the Unexpected Cause of CD4+ T-Lymphocytopenia in Two HIV-Negative Adult Female Siblings |
Q33655302 | Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency |
Q72687095 | Adenosine deaminase deficiency with altered biochemical parameters in two sisters with late-onset immunodeficiency |
Q54229015 | Adenosine deaminase deficiency: a review. |
Q24539210 | Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles |
Q40411058 | Adenosine deaminase deficiency: molecular basis and recent developments |
Q58610783 | Biallelic mutations in DNA ligase 1 underlie a spectrum of immune deficiencies |
Q45868264 | Biochemical and Immunological Status Following Gene Therapy and PEG-ADA Therapy for Adenosine Deaminase (ADA) Deficiency |
Q41521392 | Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency |
Q35889409 | Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency. |
Q77366154 | Determination of adenosine deaminase activity in human erythrocytes by on-column capillary isotachophoresis-capillary zone electrophoresis in the presence of electroosmotic flow |
Q40474529 | Diagnosis and Treatment of Inborn Errors of Purine and Pyrimidine Metabolism: An Overview |
Q43206034 | Late-onset adenosine deaminase deficiency presenting with Heck's disease |
Q28511939 | Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction |
Q43659936 | Primary immunodeficiencies. Clinical features and variant forms |
Q72011520 | Purine enzyme activities in peripheral blood mononuclear cells: comparison of a new non-radiochemical high-performance liquid chromatography procedure and a radiochemical thin-layer chromatography procedure |
Q29042256 | Severe combined immunodeficiencies (SCID) |
Q35889300 | Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery |
Q71167703 | Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency |
Q37190443 | Unravelling the association of partial T-cell immunodeficiency and immune dysregulation |
Q36455030 | Warts and all: human papillomavirus in primary immunodeficiencies |
Q40672685 | When and how does one search for inborn errors of purine and pyrimidine metabolism? |
Q41521428 | When to investigate for purine and pyrimidine disorders. Introduction and review of clinical and laboratory indications |